Erste Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Sell
1,947,728
-52,272
-3% -$435K 0.1% 191
2025
Q4
$16.6M Sell
2,000,000
-200,000
-9% -$2.15M 0.14% 148
2025
Q3
$29.1M Buy
2,200,000
+200,000
+10% +$2.39M 0.28% 95
2025
Q2
$22.5M Buy
2,000,000
+350,000
+21% +$2.71M 0.19% 114
2025
Q1
$9.4M Buy
1,650,000
+910,668
+123% +$9.28M 0.12% 161
2024
Q4
$6.98M Buy
739,332
+239,332
+48% +$2.05M 0.09% 206
2024
Q3
$4.08M Buy
500,000
+300,000
+150% +$3.01M 0.05% 262
2024
Q2
$2.67M Sell
200,000
-70,000
-26% -$2.09M 0.04% 279
2024
Q1
$12.5M Hold
270,000
0.17% 134
2023
Q4
$18.3M Buy
270,000
+59,806
+28% +$3.66M 0.27% 106
2023
Q3
$15.2M Hold
210,194
0.26% 104
2023
Q2
$15.6M Buy
210,194
+50,000
+31% +$2.96M 0.28% 102
2023
Q1
$8.52M Buy
160,194
+52,500
+49% +$3.33M 0.16% 151
2022
Q4
$7.28M Buy
107,694
+16,444
+18% +$1.51M 0.15% 158
2022
Q3
$11.4M Buy
91,250
+16,250
+22% +$1.94M 0.26% 110
2022
Q2
$7.14M Buy
75,000
+32,500
+76% +$3.96M 0.16% 157
2022
Q1
$6.85M Buy
+42,500
New +$8.27M 0.13% 186

Other funds holding DNA